Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... myelodysplastic syndromes (MDS) Phase:  ... or high risk mutations by FISH eg MLL, FLT-3 + Secondary AML, or A white blood cell count of > 50 x10^9/L ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  2. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... myelodysplastic syndromes (MDS) Phase:  ... Acute myeloid leukemia , primary or secondary Disease status: remission or <10% bone marrow blasts ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  3. AML Therapy With Irradiated Allogeneic Cells

    ... myelodysplastic syndromes (MDS) Associated Drug(s):  ... =< 1.5 mg/dl Any organ dysfunction thought to be secondary to disease will be considered separately and the patient will be ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  4. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... myelodysplastic syndromes (MDS) Gender:  ... Acute myeloid leukemia , primary or secondary Disease status: remission or <10% bone marrow blasts ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  5. Prior allogeneic transplant Karnofsky Performance Score < 70% Active central nervous system (CNS) involvement by malignant cells Patients with uncontrolled bacterial, viral or fungal infections (currently taking medication and with progre

    ... myelodysplastic syndromes (MDS) Phase:  ... de novo AML First or subsequent relapse of AML Secondary AML Treatment with institutional standard AML therapy in those ...

    Clinical Trial last updated 06/06/2016 - 2:05pm.

  6. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... myelodysplastic syndromes (MDS) Associated Drug(s):  ... institutional criteria. Any second or subsequent CR. Secondary AML with prior malignancy that has been in remission for at least 12 ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  7. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... hemoglobinuria (PNH) or myelodysplastic syndrome (MDS) associated with cytopenias. Patients with BMFS have traditionally been ... primary endpoint of this study will be cGVHD at day 365. Secondary end points include transplant related mortality, engraftment, degree ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  8. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... hemoglobinuria (PNH) or myelodysplastic syndrome (MDS) associated with cytopenias. Patients with BMFS have traditionally been ... primary endpoint of this study will be cGVHD at day 365. Secondary end points include transplant related mortality, engraftment, degree ...

    Clinical Trial last updated 04/25/2016 - 10:08am.

  9. Types of Research Articles Part I

    ... Library of Medicine. Research articles can be primary or secondary. A primary research article describes the design, methods, and results of a study. A secondary research article is a review of at least two primary research ...

    Page last updated 08/20/2015 - 12:50pm.

  10. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

    ... myelodysplastic syndromes (MDS) Phase:  ... (severe, recurrent, requiring medications, and felt to be secondary to the MPN) either after diagnosis or within 10 years before ...

    Clinical Trial last updated 05/02/2016 - 2:31pm.